IMPRiND Project

IMPRiND kick-off meeting

The IMPRiND kick-off meeting has just taken place. The meeting was hosted by the project coordinator at the University of Oxford (New College, 21-22 Mar 2017). All consortium members had the opportunity to meet, often for the first time, and get to know each other. During the two days meeting, the project idea was introduced, the work plan detailed and the work for the coming months discussed. An excellent dinner at the College restaurant completed a very pleasant and fruitful meeting.

IMPRiND project start!

On 1st March 2017 the Innovative Medicines Initiative (IMI) launched IMPRiND, an innovative research project that is devoted to investigate whether mechanisms of propagation of aggregated proteins between cells could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases. IMPRiND has a total budget of 11.4 million Euros. It is supported by the IMI with 4.7 million Euros, by industrial partners with 6.4 million Euros and 0.3 million Euros from the Swiss Federation. The project runs over four years and will end on 28 February 2021.

Show more posts

This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.